20-hydroxyeiscosatetraenoic acid may be as a predictor of malignant middle cerebral artery infarction in patients with massive middle cerebral artery infarction

BACKGROUND: Early identification of massive middle cerebral artery infarction (MCAI) at risk for malignant MCAI (m-MCAI) may be useful in selecting patients for aggressive therapies. The aim of this study was to determine whether CYP metabolites may help to predict impending m-MCAI. METHODS: This is...

Descripción completa

Detalles Bibliográficos
Autores principales: Yi, Xingyang, Zhou, Qiang, Qing, Ting, Ming, Bing, Lin, Jing, Li, Jie, Lin, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576932/
https://www.ncbi.nlm.nih.gov/pubmed/34753429
http://dx.doi.org/10.1186/s12883-021-02456-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8576932/
https://www.ncbi.nlm.nih.gov/pubmed/34753429
http://dx.doi.org/10.1186/s12883-021-02456-6

Ejemplares similares